The United States Food and Drug Administration (FDA) Friday approved a landmark gene-editing treatment for sickle cell disease. The US drug regulator “approved two milestone treatments, Casgevy and … [+2354 chars]Read More
US approves CRISPR geneediting to treat sickle cell disease DW English
